Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
46.48
+0.28 (0.61%)
Feb 4, 2026, 10:15 AM CST

SHA:688799 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,4151,3991,4031,2731,135926.86
Other Revenue
14.0614.0629.3319.211.9523.76
1,4291,4131,4331,2931,147950.63
Revenue Growth (YoY)
-1.17%-1.39%10.84%12.74%20.61%15.28%
Cost of Revenue
570.63547.62512.15421.91319.33262.39
Gross Profit
858.84865.33920.64870.75827.26688.24
Selling, General & Admin
571.82547.26595.34595.97585.96460.26
Research & Development
153.83158.33103.1888.6770.0663.66
Other Operating Expenses
31.2520.317.6816.914.0512.6
Operating Expenses
758.46726.21717.67703.76671.38538.79
Operating Income
100.38139.12202.97166.99155.89149.45
Interest Expense
-0.02-0.02----
Interest & Investment Income
98.9316.8416.0215.215.870.86
Currency Exchange Gain (Loss)
0.420.420.010.53-0.03-0.28
Other Non Operating Income (Expenses)
-1.97-1.1-0.24-0.24-0.513.55
EBT Excluding Unusual Items
197.75155.27218.76182.5161.21153.58
Gain (Loss) on Sale of Investments
-12.91-24.31----6.29
Gain (Loss) on Sale of Assets
-0.03-0.03-0.48-0.89-0.390.01
Asset Writedown
-1.5-----
Legal Settlements
---5.28--1.95-
Other Unusual Items
30.7530.7516.8713.3621.1617.19
Pretax Income
214.06161.68229.88194.96180.03164.48
Income Tax Expense
17.722.9236.8421.5719.2719.45
Earnings From Continuing Operations
196.37138.76193.04173.39160.76145.03
Minority Interest in Earnings
16.6725.5618.289.42--
Net Income
213.03164.32211.32182.8160.76145.03
Net Income to Common
213.03164.32211.32182.8160.76145.03
Net Income Growth
0.75%-22.24%15.60%13.71%10.85%25.01%
Shares Outstanding (Basic)
13213113113111299
Shares Outstanding (Diluted)
13213113113111299
Shares Change (YoY)
0.19%-0.03%0.19%17.21%13.60%0.14%
EPS (Basic)
1.621.251.611.391.441.47
EPS (Diluted)
1.621.251.611.391.441.47
EPS Growth
0.56%-22.22%15.38%-2.98%-2.43%24.84%
Free Cash Flow
-175.01-91.65108.6823.822.6350.91
Free Cash Flow Per Share
-1.33-0.700.830.180.200.52
Dividend Per Share
0.4290.4290.6430.6430.500-
Dividend Growth
-33.33%-33.33%-28.58%--
Gross Margin
60.08%61.24%64.25%67.36%72.15%72.40%
Operating Margin
7.02%9.85%14.17%12.92%13.60%15.72%
Profit Margin
14.90%11.63%14.75%14.14%14.02%15.26%
Free Cash Flow Margin
-12.24%-6.49%7.58%1.84%1.97%5.36%
EBITDA
175.2208.03263.99215.78190.11179.11
EBITDA Margin
12.26%14.72%18.43%16.69%16.58%18.84%
D&A For EBITDA
74.8268.961.0248.7934.2229.67
EBIT
100.38139.12202.97166.99155.89149.45
EBIT Margin
7.02%9.85%14.17%12.92%13.60%15.72%
Effective Tax Rate
8.27%14.17%16.03%11.06%10.70%11.83%
Revenue as Reported
1,4291,4131,4331,2931,147950.63
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.